Endocrinological analysis of 122 Japanese childhood cancer survivors in a single hospital

Endocrine Journal

Volumn 55, Issue 6, 2008, Pages 1055-1063

  Miyoshi, Yoko ^a   Ohta, Hideaki ^a   Hashii, Yoshiko ^a   Tokimasa, Sadao ^a   Namba, Noriyuki ^a   Mushiake, Sotaro ^a   Hara, Junichi ^b   Ozono, Keiichi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

Childhood cancer survivors; Endocrinological abnormality; Growth retardation; Late effects; Quality of life

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DESMOPRESSIN; HUMAN GROWTH HORMONE; LEVOTHYROXINE; MELPHALAN; SEX HORMONE; THIOTEPA;

ADOLESCENT; ADRENAL CORTEX INSUFFICIENCY; ADULT; ARTICLE; BONE DENSITY; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; CLINICAL FEATURE; CONTROLLED STUDY; CRANIOPHARYNGIOMA; DIABETES INSIPIDUS; DISEASE ASSOCIATION; DRUG WITHDRAWAL; ENDOCRINE DISEASE; FEMALE; FOLLOW UP; GROWTH HORMONE DEFICIENCY; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; HYPOTHYROIDISM; JAPANESE; MAJOR CLINICAL STUDY; MALE; OBESITY; PATIENT COMPLIANCE; RADIATION DOSE; SIDE EFFECT; SOLID TUMOR;

ADOLESCENT; ADULT; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; DIAGNOSTIC TECHNIQUES, ENDOCRINE; ENDOCRINE SYSTEM DISEASES; FEMALE; FOLLOW-UP STUDIES; GONADS; HUMANS; INCIDENCE; JAPAN; MALE; NEOPLASMS; PUBERTY; RETROSPECTIVE STUDIES; SURVIVORS; YOUNG ADULT;

EID: 58549101889     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K08E-075     Document Type: Article

References (36)

1. Foundation for promotion of cancer research (2007) Cancer statistics in Japan - 2007. HYPERLINK "http://ganjoho.ncc.go.jp/public/statistics/ backnumber/2007-jp.html"
2. American Cancer Society (2007) Cancer Facts & Figures 2007. HYPERLINK "http://www.cancer.org/docroot/STT/content/STT-1x-Cancer-Facts-Figures- 2007.asp"
3. National Institute for Health and Clinical Excellence (NICE), Service Guidelines "Improving Outcomes in Children and Young People with Cancer" (2005) HYPERLINK "http://www.nice.org.uk"
4. Dickerman JD (2007) The late effects of childhood cancer therapy. Pediatrics 119: 554-568.
5. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS, Schwartz CL, Leisenring W, Robison LL; Childhood Cancer Survivor Study (2006) Chronic Health Conditions in Adult Survivors of Childhood Cancer. N Engl J Med 355: 1572-1582.
6. Geenen MM, Cardous-Ubbink MC, Kremer LC, van den Bos C, van der Pal HJ, Heinen RC, Jaspers MW, Koning CC, Oldenburger F, Langeveld NE, Hart AA, Bakker PJ, Caron HN, van Leeuwen FE (2007) Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 297: 2705-2715.
7. Bassal M, Mertens AC, Taylor L, Neglia JP, Greffe BS, Hammond S, Ronckers CM, Friedman DL, Stovall M, Yasui YY, Robison LL, Meadows AT, Kadan-Lottick NS (2006) Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 24: 476-483.
8. Meacham L. (2003) Endocrine late effects of childhood cancer therapy. Curr Probl Pediatr Adolesc Health Care 33: 217-242.
9. Rutter MM, Rose SR (2007) Long-term endocrine sequelae of childhood cancer. Curr Opin Pediatr 19: 480-487.
10. Children's Oncology Group (2006) Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers. Version 2.0 - March 2006. HYPERLINK "http://www.survivorshipguidelines.org/"
11. SIGN Long term follow up of survivors of childhood cancer (2005) A national clinical guideline January 2004; Updated March 2005. HYPERLINK "http://www.sign.ac.uk/pdf/sign76.pdf"
12. Practice Statement "Therapy Based Long Term Follow Up" (2nd Edition, 2005). HYPERLINK "http://www.ukccsg.org.uk/public/followup/ PracticeStatement/index.html" UK Children's Cancer and Leukaemia Group (CCLG).
13. Masera G, Chesler M, Jankovic M, Eden T, Nesbit ME, Van Dongen-Melman J, Epelman C, Ben Arush MW, Schuler D, Mulhern R (1996) SIOP Working Committee on Psychosocial issues in pediatric oncology: guidelines for care of long-term survivors. Med Pediatr Oncol 27: 1-2.
14. Aslett H, Levitt G, Richardson A, Gibson F (2007) A review of long-term follow-up for survivors of childhood cancer. Eur J Cancer 43: 1781-1790.
15. Shinagawa T, Tomita Y, Ishiguro H, Matsumoto M, Shimizu T, Yasuda Y, Hattori K, Kubota C, Yabe H, Yabe M, Kato S, Shinohara O (2001) Final height and growth hormone secretion after bone marrow transplantation in children. Endocr J 48: 133-138.
16. Ishiguro H, Yasuda Y, Tomita Y, Shinagawa T, Shimizu T, Morimoto T, Hattori K, Matsumoto M, Inoue H, Yabe H, Yabe M, Shinohara O, Kato S (2007) Gonadal shielding to irradiation is effective in protecting testicular growth and function in long-term survivors of bone marrow transplantation during childhood or adolescence. Bone Marrow Transplantation 39: 483-490.
17. Maeda N, Kato K, Matsuyama T, Kojima S, Ohyama K (2003) High-Dose Busulfan is a major risk factor for ovarian dysfunction in girls after stem cell transplantation. Clin Ped Endo 12: 13-18.
18. Osteoporosis Diagnostic Criteria Review Committee, Japanese Society for Bone and Mineral Research (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19: 331-337.
19. Tanaka H (2005) Bone mineral density. Pediatrics of Japan 46 (suppl): 17-19 (In Japanese).
20. Schwartz CL, Hobbie WL, Constine LS, Ruccione KS, eds. (2005) Survivors of childhood and adolescent cancer: A multidisciplinary approach. Second edition. Germany: Springer-Verlag.
21. Haupt R, Spinetta JJ, Ban I, Barr RD, Beck JD, Byrne J, Calaminus G, Coenen E, Chesler M, D'Angio GJ, Eiser C, Feldges A, Gibson F, Lackner H, Masera G, Massimo L, Magyarosy E, Otten J, Reaman G, Valsecchi MG, Veerman AJ, Penn A, Thorvildsen A, van den Bos C, Jankovic M; International Berlin-Frankfurt- Münster Study Group Early and Late Toxicity Educational Committee (I-BFM-SG ELTEC) (2007) Long term survivors of childhood cancer: cure and care. The Erice statement. Eur J Cancer 43: 1778-1780.
22. Sklar CA (2001) Endocrine complications of the successful treatment of neoplastic diseases in childhood. Growth Genetics and Hormones 17: 37-42.
23. Chow EJ, Friedman DL, Yasui Y, Whitton JA, Stovall M, Robison LL, Sklar CA (2007) Decreased adult height in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Pediatr 150: 370-375.
24. Sanders JE (2008) Growth and development after hematopoietic cell transplant in children. Bone Marrow Transplant 41: 223-227.
25. Gleeson HK, Stoeter R, Ogilvy-Stuart AL, Gattamaneni HR, Brennan BM, Shalet SM (2003) Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement. J Clin Endocrinol Metab 88: 3682-3689.
26. Lawson Wilkins Pediatric Endocrine Society (LWPES) Writing Committee: Mark A. Sperling, Paul H. Saenger, Ray Hintz, Tom Wilson, and Susan R. Rose on behalf of the LWPES Executive Committee and the LWPES Drug and Therapeutics Committee (2002) Growth Hormone Treatment and Neoplasia - Coincidence or Consequence? J Clin Endocrinol Metab 87: 5351-5352.
27. Jenkins PJ, Mukherjee A, Shalet SM (2006) Does growth hormone cause cancer? Clin Endocrinol 64: 115-121.
28. Sklar CA, Mertens AC, Mitby P, Occhiogrosso G, Qin J, Heller G, Yasui Y, Robison LL (2002) Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 87: 3136-3141.
29. Cohen P, Clemmons DR, Rosenfeld RG (2000) Does the GH-IGF axis play a role in cancer pathogenesis? Growth Horm IGF Res 10: 297-305.
30. Swerdlow AJ, Higgins CD, Adiard P, Preece MA (2002) Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet 360: 273-277.
31. Fujita K, Ohta H, Tsujimura A, Takao T, Miyagawa Y, Takada S, Matsumiya K, Wakayama T, Okuyama A (2005) Transplantation of spermatogonial stem cells isolated from leukemic mice restores fertility without inducing leukemia. J Clin Invest 115: 1855-1861.
32. Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, Martinez-Madrid B, Langendonckt AV (2004) Live birth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364: 1405-1410.
33. Rogerio AL (2005) Potential options for preservation of fertility in women. N Engl J Med 353: 64-73.
34. Sala A, Barr RD (2007) Osteopenia and cancer in children and adolescents: the fragility of success. Cancer 109: 1420-1431.
35. Kalkwarf HJ, Zemel BS, Gilsanz V, Lappe JM, Horlick M, Oberfield S, Mahboubi S, Fan B, Frederick MM, Winer K, Shepherd JA (2007) The Bone Mineral Density in Childhood Study: Bone Mineral Content and Density According to Age, Sex, and Race. J Clin Endocrinol Metab 92: 2087-2099.
36. Michaud LB, Goodin S. (2006) Cancer-treatment-induced bone loss, part 1. Am J Health Syst Pharm 63: 419-430.